 |
 |

Consensus Needed for Evaluating Safe and Adequate Anticoagulant Control
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
We read with interest the recent article by Fitzmaurice et al.1 The primary outcome they reported was the point
prevalence of patients achieving individual therapeutic international normalized
ratio (INR) targets. Although the authors state that this method is routinely
used in England, there is no clear consensus. In an attempt to standardize
the evaluation of anticoagulant control, the INR was introduced, and disease-specific
INR target ranges were recommended.
In recent years, a variety of methods have been used to evaluate therapeutic
control of the INR in England and elsewhere. Some of the most widely used
methods include the following: (1) the proportion of INRs within target ranges2; (2) the proportion of time spent within the individual
target ranges3; (3) the proportion of INRs
within the target range ± 10%4; and
(4) the mean ± 1 SD INR for the clinic overall.5
There have been no recommendations for . . . [Full Text of this Article]
RELATED ARTICLE
Oral Anticoagulation Management in Primary Care With the Use of Computerized Decision Support and Near-Patient Testing: A Randomized, Controlled Trial
David A. Fitzmaurice, F. D. Richard Hobbs, Ellen T. Murray, Roger L. Holder, Teresa F. Allan, and Peter E. Rose
Arch Intern Med. 2000;160(15):2343-2348.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Chronic unexplained fatigue * Author's reply
Baschetti
Postgrad. Med. J. 2002;78:763-763.
FULL TEXT
|